X4 Pharmaceuticals announces common stock, warrant offering, no amount given

X4 Pharmaceuticals announced that it has commenced an underwritten public offering of shares of its common stock and accompanying warrants to purchase shares of its common stock. Piper Sandler, Stifel and Cantor are acting as joint book-running managers for the offering.